Merck to Acquire Pandion Therapeutics

2021-02-25 03:45:17

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Pandion Therapeutics, Inc. (Nasdaq: PAND) today announced that the companies have entered into a definitive agreemen